Background The Centers for Disease Control and Prevention advises that patients with
moderate to severe asthma belong to a high-risk group that is susceptible to severe …

Background Several underlying conditions have been associated with severe acute
respiratory syndrome coronavirus 2 illness, but it remains unclear whether underlying …

Rationale: Health outcomes of people with coronavirus disease (COVID-19) range from no
symptoms to severe illness and death. Asthma, a common chronic lung disease, has been …

The severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease
2019 (COVID-19), has infected more than 200 million and led to the deaths of more than 4.3 …

Background Current studies of asthma history on coronavirus disease 2019 (COVID-19)
outcomes are limited and lack consideration of disease status. Objective To conduct a …

Background The impact of asthma on coronavirus disease 2019 (COVID-19) remains largely
unknown. Objective To investigate the asthma prevalence among patients with COVID-19 …

Background Asthma prevalence among COVID-19 patients seems to be surprisingly low.
However the clinical profile of COVID-19 asthmatic patients and potential determinants of …

Background Coronavirus disease 2019 (COVID-19) has spread worldwide rapidly.
However, the effects of asthma, asthma medication and asthma severity on the clinical …

Background Bronchial asthma has not been adequately assessed in coronavirus disease
2019 (COVID-19). Respiratory allergy is associated with significant reductions in the …

Coronavirus disease 2019 (COVID-19) has afflicted at least 4.9 million patients worldwide,
causing more than 328,000 deaths to date. This pandemic impacts not only social and …